3
5

Restoring Safeguards for Dangerous Abortion Drugs Act

5/28/2025, 1:17 PM

Summary of Bill S 1631

This bill, designated as S. 1631 in the 119th Congress, aims to mandate the Secretary of Health and Human Services to endorse a risk evaluation and mitigation strategy for mifepristone that mirrors a previously approved strategy. Additional purposes of the bill are not specified in the provided context.

Current Status of Bill S 1631

Bill S 1631 is currently in the status of Bill Introduced since May 6, 2025. Bill S 1631 was introduced during Congress 119 and was introduced to the Senate on May 6, 2025.  Bill S 1631's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 6, 2025

Bipartisan Support of Bill S 1631

Total Number of Sponsors
3
Democrat Sponsors
0
Republican Sponsors
3
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 1631

Primary Policy Focus

Health

Alternate Title(s) of Bill S 1631

A bill to require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
A bill to require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.

Comments